Comment from Diagnostic Green LLC
AnonymousSupportBusiness
Summary: Diagnostic Green LLC, representing Renew Pharmaceuticals Ltd., supports the FDA's initiative to solicit input on drug repurposing. They specifically advocate for the repurposing of Indocyanine Green (ICG) for various surgical and diagnostic uses, citing its long safety record and the lack of commercial incentives for the drug sponsor to pursue new labeling.
Diagnostic Green LLC respectfully submits the attached comments in response to FDA’s Request for Information, “Drug Repurposing for Unmet Medical Needs,” Docket No. FDA-2026-N-4492.